Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L. Najun Dubos"'
Publikováno v:
Value in Health. 21:S55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2618283fa8bb0f399823ac4bdfb43349
https://doi.org/10.1016/j.jval.2018.09.324
https://doi.org/10.1016/j.jval.2018.09.324
Autor:
L. Najun Dubos, L Renati
Publikováno v:
Value in Health. 18:A442-A443
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759c35fc652eefbcdeb6895b14885ffb
https://doi.org/10.1016/j.jval.2015.09.1091
https://doi.org/10.1016/j.jval.2015.09.1091
Publikováno v:
Value in Health. 18:A267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5075a93ae357ff61cd18d4f820c4a604
https://doi.org/10.1016/j.jval.2015.03.1554
https://doi.org/10.1016/j.jval.2015.03.1554
Autor:
Eduardo Mysler, J. P. Solé, A. Alvarellos, A. Eimon, L. Najun Dubos, J. Velasco Zamora, A. Borgia, R. Garcia Salinas, Daniel Siri, C. Wiederhold, F. Sommerfleck, L. Re
Publikováno v:
Annals of the Rheumatic Diseases. 72:A411.3-A412
Background In RA patients, where biological therapy is needed, combination therapy (CT) with a biological agent plus MTX remains the standard of care. However, in some scenarios (i.e. DMARD intolerance, non-compliance) BMT appears as a therapeutic op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7764cb29a7679018cc616bda9697ba7
https://doi.org/10.1136/annrheumdis-2013-eular.1250
https://doi.org/10.1136/annrheumdis-2013-eular.1250